R script that exemplifies how genetic risk score analyses were performed in Horowitz et al. 2021 Genome-wide analysis provides genetic evidence that ACE2 expression influences COVID-19 risk and yields risk scores associated with severe disease. Nature Genetics (in press
Although some demographic, clinical and environmental factors have been associated with a higher ris...
BACKGROUND: Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome cor...
: GWAS involve testing genetic variants across the genomes of many individuals to identify genotype-...
Scripts or steps used in Horowitz et al. 2021* to: (i) perform GWAS with REGENIE; (ii) analyze RNA-s...
These R scripts can be used to reproduce the analysis for the paper: The changing relationship betwe...
Background: SARS-CoV-2, the causal agent of COVID-19, enters human cells using the ACE2 (angiotensin...
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of COV...
This is the code used for the statistical analysis performed in the manuscript entitled "Previous im...
Introduction: The course of COVID-19 varies from asymptomatic to severe in patients. The basis for ...
This contains R code used to generate figures and supplementary items reported in "Genetic feature e...
BackgroundAngiotensin-converting enzyme 2 (ACE2) is the cell-entry receptor for SARS-CoV-2. It plays...
ACE2 Geneshot AutoRIF ARCHS4 predictions were obtained by Geneshot, combining genes previously publi...
R code for analysis of trans-omics data from Wu et al., 2021. Codes for RNA-seq downstream analysis...
Objectives: Uncovering the genetic basis of COVID-19 may shed insight into its pathogenesis and help...
Background: SARS-CoV-2 virus uses angiotensin converting enzyme 2 (ACE2), a key enzyme of the renin ...
Although some demographic, clinical and environmental factors have been associated with a higher ris...
BACKGROUND: Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome cor...
: GWAS involve testing genetic variants across the genomes of many individuals to identify genotype-...
Scripts or steps used in Horowitz et al. 2021* to: (i) perform GWAS with REGENIE; (ii) analyze RNA-s...
These R scripts can be used to reproduce the analysis for the paper: The changing relationship betwe...
Background: SARS-CoV-2, the causal agent of COVID-19, enters human cells using the ACE2 (angiotensin...
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of COV...
This is the code used for the statistical analysis performed in the manuscript entitled "Previous im...
Introduction: The course of COVID-19 varies from asymptomatic to severe in patients. The basis for ...
This contains R code used to generate figures and supplementary items reported in "Genetic feature e...
BackgroundAngiotensin-converting enzyme 2 (ACE2) is the cell-entry receptor for SARS-CoV-2. It plays...
ACE2 Geneshot AutoRIF ARCHS4 predictions were obtained by Geneshot, combining genes previously publi...
R code for analysis of trans-omics data from Wu et al., 2021. Codes for RNA-seq downstream analysis...
Objectives: Uncovering the genetic basis of COVID-19 may shed insight into its pathogenesis and help...
Background: SARS-CoV-2 virus uses angiotensin converting enzyme 2 (ACE2), a key enzyme of the renin ...
Although some demographic, clinical and environmental factors have been associated with a higher ris...
BACKGROUND: Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome cor...
: GWAS involve testing genetic variants across the genomes of many individuals to identify genotype-...
DOI
Add to ORKG